Empleo, Jeacelle L.
HRN: 27-37-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/02/2025
07/09/2025
IV
500MG
Q8H
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes